All Stories

  1. Bronchiectasis insanity: Doing the same thing over and over again and expecting different results?
  2. Pulmonary rehabilitation for bronchiectasis: if not now, when?
  3. The Prevalence and Significance of Staphylococcus aureus in Patients with Non–Cystic Fibrosis Bronchiectasis
  4. The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization
  5. New Guidelines for the Treatment of Drug-Susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America. Now Comes the Hard Part
  6. Is There Any Reliable Clinical Evidence to Suggest That Acthar Is More Effective Than Other Forms of Corticosteroids in Treating Sarcoidosis and Other Diseases It Is Being Marketed to Treat?
  7. Predictors of warfarin-associated adverse events in hospitalized patients: Opportunities to prevent patient harm
  8. Predictors of In-Hospital vs Postdischarge Mortality in Pneumonia
  9. The Initial Evaluation of Adults with Bronchiectasis
  10. Throw Caution to the Wind Instruments: Response
  11. Trombone Player's Lung
  12. Antibiotic Timing and Diagnostic Uncertainty in Medicare Patients With Pneumonia
  13. Predicting Bacteremia in Patients with Community-Acquired Pneumonia
  14. Temporal Trends in Outcomes of Older Patients With Pneumonia
  15. Diagnostic Approach to Pneumocystis carinii Pneumonia in the Setting of Prophylactic Aerosolized Pentamidine* *From the Division of Pulmonary and Critical Care Medicine, University of California, San Diego Medical Center, San Diego.